1928 Diagnostics
Susanne has extensive experience from product development at AstraZeneca and also conducted academic research at Karolinska Institute. She has an excellence in biochemistry, cell and molecular biology and molecular pharmacology and has long experience from leading and participating in interdisciplinary project teams as well as generating, reporting and filing data according to regulatory requirements.
1928 Diagnostics
1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using whole genome sequencing (WGS) data, 1928 contributes to the fight against infections by identifying and characterizing superbugs to assist in tracking, controlling, and preventing outbreaks.